{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:31:16Z","timestamp":1780471876391,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Inflammatory bowel disease (IBD) and ankylosing spondylitis (AS) are similar chronic inflammatory diseases whose definitive etiology is unknown. Following recent clinical and genetic evidence supporting an intertwined pathogenic relationship, we conducted a pilot study to measure fecal calprotectin (fCAL) and IBD-related serologies in AS patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Consecutive AS patients were recruited from a long-term prospectively collected longitudinal AS cohort at Cedars-Sinai Medical Center. Controls were recruited from Cedars-Sinai Medical Center employees or spouses of patients with AS. Sera were tested by ELISA for IBD-associated serologies (antineutrophil cytoplasmic antibodies (ANCA), anti-<jats:italic>Saccharomyces cerevisiae<\/jats:italic> antibody IgG and IgA, anti-I2, anti-OmpC, and anti-CBir1). The Bath Ankylosing Spondylitis Disease Activity Index, the Bath Ankylosing Spondylitis Functional Index, and the Bath Ankylosing Spondylitis Radiology Index were completed for AS patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>A total of 81 subjects (39 AS patients and 42 controls) were included for analysis. The average age of AS patients was 47 years and the average disease duration was 22 years. AS patients were predominantly male; 76% were HLA-B27-positive. Median fCAL levels were 42 \u03bcg\/g and 17 \u03bcg\/g in the AS group and controls, respectively (<jats:italic>P<\/jats:italic> &lt; 0.001). When using the manufacturer's recommended cutoff value for positivity of 50 \u03bcg\/g, stool samples of 41% of AS patients and 10% of controls were positive for fCAL (<jats:italic>P<\/jats:italic> = 0.0016). With the exception of ANCA, there were no significant differences in antibody levels between patients and controls. Median ANCA was 6.9 ELISA units in AS patients and 4.3 ELISA units in the controls. Among AS patients stratified by fCAL level, there were statistically significant differences between patients and controls for multiple IBD-associated antibodies.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Calprotectin levels were elevated in 41% of patients with AS with a cutoff value for positivity of 50 \u03bcg\/g. fCAL-positive AS patients displayed higher medians of most IBD-specific antibodies when compared with healthy controls or fCAL-negative AS patients. Further studies are needed to determine whether fCAL can be used to identify and characterize a subgroup of AS patients whose disease might be driven by subclinical bowel inflammation.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4106","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T19:14:14Z","timestamp":1354216454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study"],"prefix":"10.1186","volume":"14","author":[{"given":"Franziska G","family":"Matzkies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan R","family":"Targan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Berel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J","family":"Landers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot PB","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11926-011-0198-2","volume":"13","author":"L Van Praet","year":"2011","unstructured":"Van Praet L, Van den Bosch F, Mielants H, Elewaut D: Mucosal inflammation in spondylarthritides: past, present, and future. Curr Rheumatol Rep. 2011, 13: 409-415. 10.1007\/s11926-011-0198-2.","journal-title":"Curr Rheumatol Rep"},{"key":"3843_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MAJ.0b013e3182514059","volume":"343","author":"J Rosenbaum","year":"2012","unstructured":"Rosenbaum J, Chandran V: Management of comorbidities in ankylosing spondylitis. Am J Med Sci. 2012, 343: 364-366. 10.1097\/MAJ.0b013e3182514059.","journal-title":"Am J Med Sci"},{"key":"3843_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0889-857X(05)70042-9","volume":"24","author":"F De Keyser","year":"1998","unstructured":"De Keyser F, Elewaut D, De Vos M, De Vlam K, Cuvelier C, Mielants H, Veys EM: Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am. 1998, 24: 785-813. 10.1016\/S0889-857X(05)70042-9. ix-x","journal-title":"Rheum Dis Clin North Am"},{"key":"3843_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/art.1780370105","volume":"37","author":"M Leirisalo-Repo","year":"1994","unstructured":"Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K: High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 1994, 37: 23-31. 10.1002\/art.1780370105.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"3843_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/rheumatology\/XXVII.suppl_2.95","volume":"27","author":"H Mielants","year":"1988","unstructured":"Mielants H, Veys EM, Cuvelier C, de Vos M: Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol. 1988, 27 (Suppl 2): 95-105.","journal-title":"Br J Rheumatol"},{"key":"3843_CR6","first-page":"2273","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Elewaut D: The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 1995, 22: 2273-2278.","journal-title":"J Rheumatol"},{"key":"3843_CR7","first-page":"2279","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Gyselbrecht L, Elewaut D: The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol. 1995, 22: 2279-2284.","journal-title":"J Rheumatol"},{"key":"3843_CR8","volume-title":"Ankylosing Spondylitis and the Spondlyoarthropathies","author":"H Mielants","year":"2006","unstructured":"Mielants H, Bosch F: Inflammatory bowel disease spondyloarthritis: epidemiology, clinical features, and treatment. Ankylosing Spondylitis and the Spondlyoarthropathies. Edited by: Weisman MH, Reveille JD, van der Heijde D. 2006, Philadelphia, PA: Mosby, 1","edition":"1"},{"key":"3843_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Gatta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, NIDDK IBD Genetics Consortium, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, et al: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008, 40: 955-962. 10.1038\/ng.175.","journal-title":"Nat Genet"},{"key":"3843_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Matthew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, et al: Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010, 42: 1118-1125. 10.1038\/ng.717.","journal-title":"Nat Genet"},{"key":"3843_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ng.764","volume":"43","author":"CA Anderson","year":"2011","unstructured":"Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Legac\u00e9 C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, B\u00fcning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, et al: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011, 43: 246-252. 10.1038\/ng.764.","journal-title":"Nat Genet"},{"key":"3843_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ng.553","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, Balschun T, Sina C, Ellinghaus D, H\u00e4sler R, Mayr G, Albrecht M, Wittig M, Buchert E, Nikolaus S, Gieger C, Wichmann HE, Sventoraityte J, Kupcinskas L, Onnie CM, Gazouli M, Anagnou NP, Strachan D, McArdle WL, Mathew CG, Rutgeerts P, Vermeire S, Vatn MH, IBSEN Study Group, Krawczak M, Rosenstiel P, Karlsen TH, Schreiber S: Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet. 2010, 42: 292-294. 10.1038\/ng.553.","journal-title":"Nat Genet"},{"key":"3843_CR13","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1093\/hmg\/ddi379","volume":"14","author":"K Yamazaki","year":"2005","unstructured":"Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, Cardon L, Takazoe M, Tanaka T, Ichimori T, Saito S, Sekine A, Iida A, Takahashi A, Tsunoda T, Lathrop M, Nakamura Y: Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005, 14: 3499-3506. 10.1093\/hmg\/ddi379.","journal-title":"Hum Mol Genet"},{"key":"3843_CR14","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.22812","volume":"56","author":"B Thjodleifsson","year":"2007","unstructured":"Thjodleifsson B, Geirsson AJ, Bjornsson S, Bjarnason I: A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 2007, 56: 2633-2639. 10.1002\/art.22812.","journal-title":"Arthritis Rheum"},{"key":"3843_CR15","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3899\/jrheum.100889","volume":"37","author":"JD Taurog","year":"2010","unstructured":"Taurog JD: The role of HLA-B27 in spondyloarthritis. J Rheumatol. 2010, 37: 2606-2616. 10.3899\/jrheum.100889.","journal-title":"J Rheumatol"},{"key":"3843_CR16","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3748\/wjg.15.2449","volume":"15","author":"C Salvarani","year":"2009","unstructured":"Salvarani C, Fries W: Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009, 15: 2449-2455. 10.3748\/wjg.15.2449.","journal-title":"World J Gastroenterol"},{"key":"3843_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/BOR.0b013e3283393807","volume":"22","author":"P Jacques","year":"2010","unstructured":"Jacques P, Elewaut D, Mielants H: Interactions between gut inflammation and arthritis\/spondylitis. Curr Opin Rheumatol. 2010, 22: 368-374. 10.1097\/BOR.0b013e3283393807.","journal-title":"Curr Opin Rheumatol"},{"key":"3843_CR18","doi-asserted-by":"publisher","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","volume":"6","author":"P Danoy","year":"2010","unstructured":"Danoy P, Pryce K, Hadler J, Bradbury LA, Farrar C, Pointon J, Australo-Anglo-American Spondyloarthritis Consortium, Ward M, Weisman M, Reveille JD, Wordsworth BP, Stone MA, Spondyloarthritis Research Consortium of Canada, Maksymowych WP, Rahman P, Gladman D, Inman RD, Brown MA: Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet. 2010, 6: e1001195-10.1371\/journal.pgen.1001195.","journal-title":"PLoS Genet"},{"key":"3843_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","volume":"33","author":"O Martinez-Gonzalez","year":"1994","unstructured":"Martinez-Gonzalez O, Cantero-Hinojosa J, Paule-Sastre P, Gomez-Magan JC, Salvatierra-Rios D: Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol. 1994, 33: 644-647. 10.1093\/rheumatology\/33.7.644.","journal-title":"Br J Rheumatol"},{"key":"3843_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/gut.42.6.788","volume":"42","author":"JF Quinton","year":"1998","unstructured":"Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D: Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998, 42: 788-791. 10.1136\/gut.42.6.788.","journal-title":"Gut"},{"key":"3843_CR21","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","volume":"128","author":"SR Targan","year":"2005","unstructured":"Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas E, Elson CO, Hershberg RM: Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005, 128: 2020-2028. 10.1053\/j.gastro.2005.03.046.","journal-title":"Gastroenterology"},{"key":"3843_CR22","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1186\/ar2866","volume":"11","author":"ML Mundwiler","year":"2009","unstructured":"Mundwiler ML, Mei L, Landers CJ, Reveille JD, Targan S, Weisman MH: Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study. Arthritis Res Ther. 2009, 11: R177-10.1186\/ar2866.","journal-title":"Arthritis Res Ther"},{"key":"3843_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/rheumatology\/kem324","volume":"47","author":"SZ Aydin","year":"2008","unstructured":"Aydin SZ, Atagunduz P, Temel M, Bicakcigil M, Tasan D, Direskeneli H: Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology (Oxford). 2008, 47: 142-144.","journal-title":"Rheumatology (Oxford)"},{"key":"3843_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000080081","volume":"70","author":"HP Torok","year":"2004","unstructured":"Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H, Marker-Hermann E, Folwaczny C: Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion. 2004, 70: 49-54. 10.1159\/000080081.","journal-title":"Digestion"},{"key":"3843_CR25","first-page":"920","volume":"31","author":"L Riente","year":"2004","unstructured":"Riente L, Chimenti D, Pratesi F, Delle Sedie A, Tommasi S, Tommasi C, Bombardieri S, Migliorini P: Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol. 2004, 31: 920-924.","journal-title":"J Rheumatol"},{"key":"3843_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","volume":"12","author":"MR Konikoff","year":"2006","unstructured":"Konikoff MR, Denson LA: Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflammatory Bowel Dis. 2006, 12: 524-534. 10.1097\/00054725-200606000-00013.","journal-title":"Inflammatory Bowel Dis"},{"key":"3843_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/gut.47.4.506","volume":"47","author":"J Tibble","year":"2000","unstructured":"Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I: A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000, 47: 506-513. 10.1136\/gut.47.4.506.","journal-title":"Gut"},{"key":"3843_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00005176-200102000-00015","volume":"32","author":"SK Bunn","year":"2001","unstructured":"Bunn SK, Bisset WM, Main MJ, Golden BE: Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001, 32: 171-177. 10.1097\/00005176-200102000-00015.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3843_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/ard.2006.060293","volume":"66","author":"W Lee","year":"2007","unstructured":"Lee W, Reveille JD, Davis JC, Learch TJ, Ward MM, Weisman MH: Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007, 66: 633-638. 10.1136\/ard.2006.060293.","journal-title":"Ann Rheum Dis"},{"key":"3843_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27: 361-368. 10.1002\/art.1780270401.","journal-title":"Arthritis Rheum"},{"key":"3843_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"CJ Landers","year":"2002","unstructured":"Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Targan SR: Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002, 123: 689-699. 10.1053\/gast.2002.35379.","journal-title":"Gastroenterology"},{"key":"3843_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ibd.20106","volume":"13","author":"KA Papadakis","year":"2007","unstructured":"Papadakis KA, Yang H, Ippoliti A, Mei L, Elson CO, Hershberg RM, Vasiliauskas EA, Fleshner PR, Abreu MT, Taylor K, Landers CJ, Rotter JI, Targan SR: Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflammatory Bowel Dis. 2007, 13: 524-530. 10.1002\/ibd.20106.","journal-title":"Inflammatory Bowel Dis"},{"key":"3843_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/00365521.2011.648953","volume":"47","author":"E Klingberg","year":"2012","unstructured":"Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d'Elia H: Calprotectin in ankylosing spondylitis - frequently elevated in feces, but normal in serum. Scand J Gastroenterol. 2012, 47: 435-444. 10.3109\/00365521.2011.648953.","journal-title":"Scand J Gastroenterol"},{"key":"3843_CR34","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3899\/jrheum.110508","volume":"38","author":"ML Stoll","year":"2011","unstructured":"Stoll ML, Punaro M, Patel AS: Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J Rheumatol. 2011, 38: 2274-2275. 10.3899\/jrheum.110508.","journal-title":"J Rheumatol"},{"key":"3843_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","volume":"20","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Baeten D: Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006, 20: 451-471. 10.1016\/j.berh.2006.03.010.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3843_CR36","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997, 337: 1029-1035. 10.1056\/NEJM199710093371502.","journal-title":"N Engl J Med"},{"key":"3843_CR37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ: Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999, 340: 1398-1405. 10.1056\/NEJM199905063401804.","journal-title":"N Engl J Med"},{"key":"3843_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","volume":"116","author":"FJ Baert","year":"1999","unstructured":"Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ: Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology. 1999, 116: 22-28. 10.1016\/S0016-5085(99)70224-6.","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"3843_CR39","first-page":"A105","volume":"128","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Licentenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF: A randomized placebo-controlled trial of infliximab for active ulcerative colitis: the ACT I trial. Gastroenterology. 2005, 128 (Suppl 2): A105-","journal-title":"Gastroenterology"},{"key":"3843_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/ard.62.1.74","volume":"62","author":"H Marzo-Ortega","year":"2003","unstructured":"Marzo-Ortega H, McGonagle D, O'Connor P, Emery P: Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis. Ann Rheum Dis. 2003, 62: 74-76. 10.1136\/ard.62.1.74.","journal-title":"Ann Rheum Dis"},{"key":"3843_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00535-009-0102-2","volume":"44","author":"K Higuchi","year":"2009","unstructured":"Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T: Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol. 2009, 44: 879-888. 10.1007\/s00535-009-0102-2.","journal-title":"J Gastroenterol"},{"key":"3843_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","volume":"102","author":"AC von Roon","year":"2007","unstructured":"von Roon AC, Karamountzos L, Purkayastha S, Reese GE, Darzi AW, Teare JP, Paraskeva P, Tekkis PP: Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007, 102: 803-813. 10.1111\/j.1572-0241.2007.01126.x.","journal-title":"Am J Gastroenterol"},{"key":"3843_CR43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Spondyloarthritis Research Consortium of Canada, Morgan A, Marzo-Ortega H, Bowness P, et al: Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011, 43: 761-767. 10.1038\/ng.873.","journal-title":"Nat Genet"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4106\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:48:42Z","timestamp":1728384522000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,12]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1186\/ar4106","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]},"assertion":[{"value":"20 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R261"}}